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iProphylactic Perioperative Anti-Thrombotics in Open and Endovascu-
lar Abdominal Aortic Aneurysm (AAA) Surgery: A Systematic Review
Wiersema A.M., Jongkind V., Bruijninckx C.M.A., Reijnen M.M.P.J., Vos
J.A., van Delden O.M., Zeebregts C.J., Moll F.L.The CAPPA study group
(Consensus on Arterial PeriProcedural Anticoagulation) Eur J Vasc Endo-
vasc Surg 2012;44:359-67.
Objective:Heparin is used worldwide by vascular surgeons as prophy-
laxis for arterial thrombo-embolic complications during open and endovas-
cular arterial surgery. Possible harmful effect of heparin use is more periop-
erative blood loss, resulting in a higher morbidity and mortality. To evaluate
the evidence for the use of heparin during aorto-iliac arterial surgery a review
was performed.
Methods: A systematic review was performed of literature fromMED-
LINE, EMBASE and Cochrane databases, last search performed on March
8, 2012.
Results: For open surgery for abdominal aortic aneurysm (AAA), only
5 studies were eligible for review and for endovascular aneurysm repair
(EVAR) only 1 study. Overall methodological quality of the included studies
was poor. One randomised trial could be retrieved. Possible harmful effects
of heparin were found of increasing operation time, more blood loss and
more transfusion requirements when heparin was used for open AAA surgery
in one study. No data were found comparing heparin to no intervention for
EVAR. One study compared heparin to a direct thrombin antagonist during
EVAR, showing no differences in clinical outcomes.
Conclusion: Despite limitations this review showed no compelling
evidence on the beneficiary effect of the prophylactic perioperative use of
heparin during open surgery for (r)AAA. Authors will promote a randomised
controlled multi-center trial on this topic for elective open surgical repair of
AAA.
Early Results from the ENGAGE Registry: Real-world Performance of
the Endurant Stent Graft for Endovascular AAA Repair in 1262
Patients
Stokmans R.A., Teijink J.A.W., Forbes T.L., Böckler D., Peeters P.J.,
Riambau V., Hayes P.D., van Sambeek M.R.H.M. Eur J Vasc Endovasc
Surg 2012;44:369-75.
Objective: The ENGAGE registry was undertaken to examine the
real-world outcome after endovascular abdominal aortic aneurysm (AAA)
repair (EVAR) with the Endurant Stent Graft in a large, contemporary,
global series of patients.
Methods: FromMarch 2009 to April 2011, 1262AAA patients (89.6%
men; mean age 73.1 years, range 43–93 years) were enrolled from 79 sites in
30 countries and treated with Endurant. Results are described following the
reporting standards for EVAR. Follow-up data were tabulated for all 1262
patients at a 30-day follow-up and for the first 500 patients at a 1-year
follow-up.
Results: Intra-operative technical success was achieved in 99.0% of
cases. Within 30 days, adverse events were reported in 3.9% of patients,
including a 1.3% mortality rate. Type-I or –III endoleaks were identified in
1.5% of cases. Estimated overall survival, aneurysm-related survival and
freedom from secondary interventions at 1 year were 91.6%, 98.6% and
95.1%, respectively. At 1 year, aneurysm size increased 5 mm in 2.8% and
decreased 5 mm in 41.3% of cases.
Conclusion: Early results from this real world, global experience are
promising and indicate that endovascular AAA repair with the Endurant
Stent Graft is safe and effective across different geographies and standards of
practice. Longer-term follow-up is necessary to assess durability of these
results.
Endovascular Treatment of Infected Aortic Aneurysms
Sedivy P., Spacek M., El Samman K., Belohlavek O., Mach T., Jindrak V.,
Rohn V., Stadler P. Eur J Vasc Endovasc Surg 2012;44:385-94.
Objective:To report on the short- and long-term outcomes of patients
with primary infected aortic aneurysm (IAA) treated by stent graft (SG) in
two centers.
Material andmethod:Over a period of 15 years, 32 patients with IAA
underwent endovascular treatment. None had undergone previous aortic
surgery. The causal relationship was gastrointestinal infection in 9 patients
(28%), endovascular diagnostic/therapeutic procedures/resuscitation in 6
n
p
118219%), wound infection after previous surgeries in 5 (16%), urinary infection
n 4 (13%), urology or gastroenterology procedures in 3 (9%), pancreatitis in
(6%), endocarditis in 1 (3%) and phlebitis in 1 (3%) patient. We implanted
1 bifurcated, 10 tubular thoracic, 4 aorto-uni-iliac, 4 tubular abdominal
nd 1 iliac SG. Two other surgeries were hybrid procedures.
Results: The etiological agent was identified in 28 (88%) patients.
wenty-six (81%) patients survived the 30-day postoperative period. Sixteen
50%) survived to 1-year follow-up and 13 (40.6%) survived to 3-year
ollow-up. Three patients have survived for less than 1 year and a further 3
or less than 3 years, so far. Among patients with aneurysms situated in
entral parts of the thoracic and infrarenal aorta there was a better death/
urvival ratio than among patients with a proximal or distal aneurysm
ocation.
Conclusion: The implantation of a SG may be an alternative to open
urgery in selected groups of patients with primary IAA. Aneurysms of the
entral part of the thoracic or abdominal aorta have a more favorable
rognosis with endovascular treatment.
perator-controlled Imaging Significantly Reduces Radiation Expo-
ure during EVAR
eachG., Sinha S., Black S.A.,Morgan R.A., Loftus I.M., ThompsonM.M.,
inchliffe R.J. Eur J Vasc Endovasc Surg 2012;44:395-8.
Introduction: Adoption of endovascular aneurysm repair (EVAR)
as led to significant reductions in the short-term morbidity and mortal-
ty associated with abdominal aortic aneurysm (AAA) repair. However,
VAR may expose both patient and interventionalist to potentially
armful levels of radiation, particularly as more complex procedures are
ndertaken. The aim of this study was to assess whether changing from
adiographer-controlled imaging to a system of operator-controlled im-
ging (OCI) would influence radiation exposure, screening time or
ontrast dose during EVAR.
Method: Retrospective analysis identified patients that had undergone
lective EVAR for infra-renal AAA before or after the change to operator-
ontrolled imaging. Data were collected for radiation dose (measured as
ose area product; DAP), screening time, total delivered contrast volume
nd operative duration. Data were also collected for maximum aneurysm
iameter, patient age, gender and body mass index.
Results: 122 patients underwent EVAR for infra-renal AAA at a
ingle centre between January 2011 and December 2011. 57 of these
ere prior to installation of OCI and 65 after installation. Median DAP
as significantly lower after installation of OCI (4.9 mGy m2; range
.25–13.3) than it had been before installation (6.9 mGy m2; range
.91–95.0) (p  0.005). Median screening times before and after instal-
ation of OCI were 20.0 min and 16.2 min respectively (p  0.027) and
edian contrast volumes before and after the change to OCI were
00 ml and 90 ml respectively (p  0.21).
Conclusion: Introduction of operator-controlled imaging can signifi-
antly reduce radiation exposure during EVAR, with particular reduction in
he number of ‘higher-dose’ cases.
n-Situ Revascularisation for Secondary Aorto-enteric Fistulae: The
uccess of Silver-coated Dacron is Closely Linked to a Suitable Bowel
epair
elva J.C., Déglise S., Bérard X., Dubuisson V., Delva F., Stecken L.,
ucasse E., Midy D. Eur J Vasc Endovasc Surg 2012;44:417-24.
Objectives: The purpose of this study was to assess short- and mid-
erm results of in-situ revascularisation (ISR) using silver-coated Dacron
rostheses and bowel repair for management of secondary aorto-enteric
stulae (SAEF).
Design: Single-centre retrospective chart review.
Material and methods: This study includes all the patients treated by
SR using silver-coated Dacron for SAEF between 2006 and 2010. Primary
nd points were mortality and survival rates. Secondary end points were
einfection-free survival and secondary patency rates.
Results: Eighteen male patients with SAEF with a median age of 64
ears were operated by ISR using silver-coated Dacron during the study
eriod without operative death. The 30-day mortality was 22% and the
n-hospital mortality rate was 39%. Indeed, during hospitalisation, a duode-
al leak was observed in four patients including three who died. Four others
atients died due to multi-system organ failure. Median follow-up was 16
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Volume 56, Number 4 Abstracts 1183months (range 1–66). The survival rate at 12 months was 55%. One
duodenal leak was observed leading to death. The reinfection-free survival
and the secondary patency rates at 12 months were 60% and 89%, respec-
tively.
f
rConclusion: In-situ revascularisation with silver-coated Dacron pro-
ides acceptable results in terms of mortality. This treatment may be useful
or simple vascular reconstruction and allow greater attention to bowel
epair that is a determinant in short- and mid-term survival.
